Thu, October 3, 2024
Wed, September 25, 2024
[ 12:00 AM ] - WOPRAI
Mon, September 23, 2024
[ 12:00 AM ] - WOPRAI
Tue, September 17, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, September 5, 2024
[ 12:00 AM ] - WOPRAI
Mon, August 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, July 26, 2024
[ 12:00 AM ] - WOPRAI
Tue, July 23, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 10, 2024
[ 12:00 AM ] - WOPRAI
Fri, June 14, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 17, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 14, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 9, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 22, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 16, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 15, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 1, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 28, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 21, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 15, 2024
[ 12:00 AM ] - WOPRAI
Tue, December 19, 2023
[ 12:00 AM ] - WOPRAI
Wed, November 15, 2023
[ 12:00 AM ] - WOPRAI
Mon, November 13, 2023
[ 12:00 AM ] - WOPRAI
Wed, October 11, 2023
Wed, August 9, 2023
[ 12:00 AM ] - WOPRAI
Tue, June 27, 2023
Tue, May 16, 2023
[ 12:00 AM ] - WOPRAI
Mon, May 15, 2023
Leland Gershell Initiated (BBIO) at Hold on, Oct 3rd, 2024
Leland Gershell of Oppenheimer, Initiated "BridgeBio Pharma, Inc." (BBIO) at Hold on, Oct 3rd, 2024.
Leland has made no other calls on BBIO in the last 4 months.
There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 0 agree with Leland's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Leland
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Wednesday, October 2nd, 2024
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $70 on, Monday, September 16th, 2024
- Geoff Meacham of "B of A Securities" Maintained at Strong Buy and Held Target at $42 on, Wednesday, September 11th, 2024
- Biren Amin of "Piper Sandler" Initiated at Buy and Held Target at $46 on, Wednesday, September 4th, 2024
- Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Decreased Target to $45 on, Wednesday, August 7th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $43 on, Wednesday, August 7th, 2024
Contributing Sources